Life Spine Announces Initiation of PROLIFT Expandable Interbody Clinical Study

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders announced today the initiation of the PROLIFT Expandable Clinical Study with Dr. Ahmad Khan of Central Connecticut Neurosurgery and Spine in Southington, Connecticut.

Mariusz Knap, Vice President of Marketing and Business Development notes, “Clinical Studies are the foundation for advancing innovative spine care and Life Spine is committed to a robust investment into clinical studies to evaluate the safety and efficacy of our products, as well as demonstrating possible medical economic savings and advantages associated with new technologies such as PROLIFT.”

PROLIFT Expandable Interbody System allows for in-situ disc height restoration for micro-invasive PLIF, traditional TLIF and oblique TLIF approaches. PROLIFT also incorporates the proprietary surface technology OSSEO-LOC and multiple lordotic options which provide the surgeon the ability to restore normal spinal pelvic parameters.

Dr. Ahmad Khan who is principal investigator for the clinical study notes, “Expandable interbodies have been effective to restore or maintain lumbar lordosis and disc height with reduced iatrogenic impact. However, outcome studies need to be performed to allay clinical ethicists and evaluate long-term patient outcomes”

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit:

Life Spine is a registered trademark.



Mr. Omar Faruqi
Chief Financial Officer


Source: Life Spine

Back to news